Northwestern Medicine Kishwaukee Hospital

Patient Safety - All

Healthcare-Associated Infections

Hospitals in Illinois are participating in programs to reduce the number of infections acquired during hospital stays. While it is difficult to reduce infections to zero, following specific protocols can greatly reduce the risk.

The Hospital Report Card Act (Illinois Public Act 93-563) requires Illinois hospitals to report central line associated bloodstream infections (CLABSIs) as well as surgical site infections (SSIs). As of January 1, 2012, hospitals are also mandated to report Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections and Clostridioides difficileinfections. Infections are reported through the CDC’s National Healthcare Safety Network (NHSN) surveillance system. The Standardized Infection Ratio (SIR), a summary measure used to determine whether infection data are statistically different from the national average, is presented for each type of infection shown below. Read more about healthcare-associated infections in Illinois. To learn more about the data collection methods using the CDC's National Health Safety Network (NHSN) surveillance system, read the Report Card methodology.

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
44	Complete Reporting: Too few central line days to calculate a precise SIR
45	Complete Reporting: Zero infections. Number of predicted LabID events too low to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
48	No Target Procedures Performed
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR). Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
44	Complete Reporting: Too few central line days to calculate a precise SIR
45	Complete Reporting: Zero infections. Number of predicted LabID events too low to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
48	No Target Procedures Performed
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Adult CLABSI

Pediatric CLABSI

Ped. CLABSI Measure	Result	SIR
Pediatric Medical-Surgical ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: 0.00 ³⁸	N/A infections, N/A central-line days ³⁸	0.00 ³⁸

NICU CLABSI

NICU CLABSI Measure	Result	SIR
Level III Neonatal ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection data in the Level III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹

Surgical Site Infections (SSIs)

Presented below are data for surgical site infections associated with coronary artery bypass graft surgery (CABG) and total knee replacement surgery (KPROs) using the Standardized Infection Ratio (SIR). Superficial and secondary surgical site infections are not included in the summary data below. Statewide summaries of surgical site infection data arranged by surgical procedure (CABG, KPRO) and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
44	Complete Reporting: Too few central line days to calculate a precise SIR
45	Complete Reporting: Zero infections. Number of predicted LabID events too low to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
48	No Target Procedures Performed
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Immunization Practices

Illinois hospitals are focusing their efforts on boosting immunization treatments and strengthening patient safety protocols. The objective is not merely achieving statistical success, but also enhancing the quality of care and patient well-being.

Data on immunization measures in Illinois hospitals is available through the Medicare comparison tool at medicare.gov/hospitalcompare. This tool provides valuable insights, allowing patients and their families to gauge the quality of care and safety practices at local hospitals, helping them make informed healthcare decisions.

In the realm of Patient Safety, a host of measures are assessed, with risk-adjusted rates available for each. These measures encompass various aspects of patient care and treatment outcomes. However, interpreting these metrics requires an understanding of the complexity and context-specific nature of healthcare.

Immunization

These indicators are used to measure immunization treatments at hospitals. This data comes from medicare.gov/hospitalcompare.

Measure	Result
Healthcare workers given influenza vaccination Q4 2022 - Q1 2023 Result 97.00 %	97.00 %
Description Influenza Vaccination Coverage among Healthcare Personnel Historical Data
Measure	Result
Q4 2021 - Q1 2022 Result 93.00 %	93.00 %
Q4 2020 - Q1 2021 Result 97.00 %	97.00 %
Q4 2019 - Q1 2020 Result N/A %	N/A %
Q4 2018 - Q1 2019 Result 99.00 %	99.00 %
Q4 2017 - Q1 2018 Result 99.00 %	99.00 %

Illinois Hospital Report Card

and Consumer Guide to Health Care

Northwestern Medicine Kishwaukee Hospital

Patient Safety - All

Healthcare-Associated Infections

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Central Line Associated Bloodstream Infections (CLABSIs)

Statistical Significance

Footnotes

Adult CLABSI

Description

Historical Data

Pediatric CLABSI

Description

Historical Data

NICU CLABSI

Description

Historical Data

Surgical Site Infections (SSIs)

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Immunization Practices

Immunization

Description

Historical Data

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 4 infections, 30429 patient days Rating SIR: 3.32	4 infections, 30429 patient days	3.32
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 0 infections, 29686 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 29686 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2021 - Q4 2021 Result 0 infections, 28943 patient days ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 28943 patient days ¹¹⁸	N/A ¹¹⁸
Q1 2019 - Q4 2019 Result 3 infections, 26453 patient days ⁴⁷ Rating SIR: N/A ⁴⁷	3 infections, 26453 patient days ⁴⁷	N/A ⁴⁷
Q1 2018 - Q4 2018 Result 1 infections, 27299 patient days ⁴⁷ Rating SIR: N/A ⁴⁷	1 infections, 27299 patient days ⁴⁷	N/A ⁴⁷
Q1 2017 - Q4 2017 Result 2 infections, 21689 patient days ⁴⁷ Rating SIR: N/A ⁴⁷	2 infections, 21689 patient days ⁴⁷	N/A ⁴⁷
Q1 2016 - Q4 2016 Result 1 infections, 23338 patient days ⁴⁷ Rating SIR: N/A ⁴⁷	1 infections, 23338 patient days ⁴⁷	N/A ⁴⁷
Q1 2015 - Q4 2015 Result 0 infections, 23308 patient days ⁴⁷ Rating SIR: N/A ⁴⁷	0 infections, 23308 patient days ⁴⁷	N/A ⁴⁷
Q1 2014 - Q4 2014 Result 1 infections, 21784 patient days ⁴⁷ Rating SIR: N/A ⁴⁷	1 infections, 21784 patient days ⁴⁷	N/A ⁴⁷
Q1 2013 - Q4 2013 Result 2 infections, 22380 patient days ¹¹⁴ Rating SIR: N/A ¹¹⁴	2 infections, 22380 patient days ¹¹⁴	N/A ¹¹⁴
Q1 2012 - Q4 2012 Result 0 infections, 20960 patient days ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 20960 patient days ¹¹⁸	N/A ¹¹⁸
Q1 2012 - Q2 2012 Result 0 infections, 10779 patient days Rating SIR: 0.00	0 infections, 10779 patient days	0.00
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 2 infections, 29306 patient days Rating SIR: 0.18	2 infections, 29306 patient days	0.18
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 2 infections, 28365 patient days Rating SIR: 0.19	2 infections, 28365 patient days	0.19
Q1 2021 - Q4 2021 Result 3 infections, 27505 patient days Rating SIR: 0.24	3 infections, 27505 patient days	0.24
Q1 2019 - Q4 2019 Result 6 infections, 25243 patient days Rating SIR: 0.41	6 infections, 25243 patient days	0.41
Q1 2018 - Q4 2018 Result 11 infections, 26067 patient days Rating SIR: 0.77	11 infections, 26067 patient days	0.77
Q1 2017 - Q4 2017 Result 21 infections, 20439 patient days Rating SIR: 1.52	21 infections, 20439 patient days	1.52
Q1 2016 - Q4 2016 Result 12 infections, 21499 patient days Rating SIR: 1.05	12 infections, 21499 patient days	1.05
Q1 2015 - Q4 2015 Result 17 infections, 21438 patient days Rating SIR: 1.49	17 infections, 21438 patient days	1.49
Q1 2014 - Q4 2014 Result 16 infections, 20399 patient days Rating SIR: 1.47	16 infections, 20399 patient days	1.47
Q1 2013 - Q4 2013 Result 19 infections, 21119 patient days Rating SIR: 1.38	19 infections, 21119 patient days	1.38
Q1 2012 - Q4 2012 Result 7 infections, 19789 patient days Rating SIR: 0.50	7 infections, 19789 patient days	0.50

Adult CLABSI Measure	Result	SIR
Adult Medical/Surgical ICU Q1 2023 - Q4 2023 Result 1 infections, 1033 central-line days Rating SIR: N/A	1 infections, 1033 central-line days	N/A
Description Central Line-associated Bloodstream Infection data in the Adult Medical/Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 0 infections, 1157 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 1157 central-line days ⁴²	N/A ⁴²
Q1 2021 - Q4 2021 Result 0 infections, 1241 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 1241 central-line days ⁴²	N/A ⁴²
Q1 2020 - Q4 2020 Result 0 infections, 784 central-line days Rating SIR: N/A	0 infections, 784 central-line days	N/A
Q1 2019 - Q4 2019 Result 0 infections, 1079 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 1079 central-line days ⁴²	N/A ⁴²
Q1 2018 - Q4 2018 Result 1 infections, 1254 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	1 infections, 1254 central-line days ⁴⁴	N/A ⁴⁴
Q1 2017 - Q4 2017 Result 1 infections, 1256 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	1 infections, 1256 central-line days ⁴⁴	N/A ⁴⁴
Q1 2016 - Q4 2016 Result 0 infections, 1263 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	0 infections, 1263 central-line days ⁴⁴	N/A ⁴⁴
Q1 2015 - Q4 2015 Result 1 infections, 1017 central-line days Rating SIR: 0.66	1 infections, 1017 central-line days	0.66
Q1 2014 - Q4 2014 Result 1 infections, 1270 central-line days Rating SIR: 0.53	1 infections, 1270 central-line days	0.53
Q1 2013 - Q4 2013 Result 0 infections, 1023 central-line days ⁴⁶ Rating SIR: 0.00 ⁴⁶	0 infections, 1023 central-line days ⁴⁶	0.00 ⁴⁶
Q1 2012 - Q4 2012 Result 1 infections, 1140 central-line days Rating SIR: 0.59	1 infections, 1140 central-line days	0.59
Q1 2011 - Q4 2011 Result 1 infections, 1107 central-line days Rating SIR: 0.60	1 infections, 1107 central-line days	0.60
Q1 2010 - Q4 2010 Result 1 infections, 979 central-line days Rating SIR: 0.68	1 infections, 979 central-line days	0.68
Q1 2009 - Q4 2009 Result 0 infections, 1031 central-line days Rating SIR: 0.00	0 infections, 1031 central-line days	0.00
Q1 2009 - Q2 2009 Result 0 infections, 517 central-line days Rating SIR: 0.00	0 infections, 517 central-line days	0.00

SSI Measure	Result	SIR
Total Knee Replacement Surgery Q1 2020 - Q4 2020 Result 0 infections, 66 procedures ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 66 procedures ¹¹⁸	N/A ¹¹⁸
Description Surgical Site Infections Associated with Total Knee Replacement Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result 0 infections, 152 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 152 procedures ¹⁵³	N/A ¹⁵³
Q1 2018 - Q4 2018 Result 0 infections, 150 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 150 procedures ¹⁵³	N/A ¹⁵³
Q1 2017 - Q4 2017 Result 0 infections, 169 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 169 procedures ¹⁵³	N/A ¹⁵³
Q1 2016 - Q4 2016 Result 0 infections, 143 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 143 procedures ¹⁵³	N/A ¹⁵³
Q1 2015 - Q4 2015 Result 0 infections, 193 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 193 procedures ¹⁵³	N/A ¹⁵³
Q1 2014 - Q4 2014 Result 0 infections, 190 procedures Rating SIR: N/A	0 infections, 190 procedures	N/A
Q3 2013 - Q2 2014 Result 0 infections, 182 procedures ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 182 procedures ¹¹⁸	N/A ¹¹⁸
Q3 2012 - Q2 2013 Result 0 infections, 214 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 214 procedures ¹¹⁷	0.00 ¹¹⁷
Q3 2011 - Q2 2012 Result 0 infections, 167 procedures ⁴⁵ Rating SIR: N/A ⁴⁵	0 infections, 167 procedures ⁴⁵	N/A ⁴⁵
Q3 2010 - Q2 2011 Result 0 infections, 123 procedures ⁴⁵ Rating SIR: N/A ⁴⁵	0 infections, 123 procedures ⁴⁵	N/A ⁴⁵
Coronary Artery Bypass Graft Surgery Q1 2020 - Q4 2020 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Description Surgical Site Infections Associated with Coronary Artery Bypass Graft Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2018 - Q4 2018 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2016 - Q4 2016 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A procedures Rating SIR: N/A	N/A infections, N/A procedures	N/A
Q3 2013 - Q2 2014 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2012 - Q2 2013 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2011 - Q2 2012 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2010 - Q2 2011 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸